Cheribundi Cheers Cash Infusion, Steers Toward Retail
Cherries have always had a strong association with Valentine’s Day, but last Feb. 14 was especially sweet for the team at CherryPharm, the company behind the line of tart cherry juices that are now known as Cheribundi. That’s because the company consummated a deal of a different kind on the holiday, closing a $4.5 million equity round led by Greenwich-based Emil Capital Partners, along with its previous lead investor, Cayuga Venture Fund, and other shareholders.